$MET · METLIFE INC
MetLife filed its Q3 FY2026 10-Q. Net income attributable to MetLife, Inc. was $2.397B versus $896M a year ago, and net income available to common shareholders was $2.351B versus $818M. Total revenues rose 18.2% to $20.522B, driven by higher premiums ($11.818B vs $10.555B) and a swing in net derivative gains to $698M from a $929M loss. Total consolidated adjusted earnings were $1.826B versus $1.650B.
- Net income available to common shareholders rose to $2.351B from $818M in Q3 2025.
- Total revenues increased 18.2% YoY to $20.522B.
- Net derivative gains swung to $698M from a $929M loss a year earlier.
- Total consolidated adjusted earnings rose to $1.826B from $1.650B.
- Total equity fell to $22.519B from $28.680B at year-end 2025 on higher AOCI losses.
Markets closed — no regular-session reaction yet; extended-hours move not captured here.
A 187% jump in common-shareholder net income on an 18.2% revenue gain shows strong operating momentum, though the derivative-driven swing warrants scrutiny.
Life insurers' results remain sensitive to derivative and investment gains/losses, with MetLife's swing in net derivative gains a key driver of the YoY earnings jump.
Accumulated other comprehensive loss widened to $25.304B from $18.084B, pressuring book value; total equity fell to $22.519B from $28.680B. Net investment losses deepened to $430M from $325M.